[HTML][HTML] Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma

Y Qian, Y Gong, Z Fan, G Luo, Q Huang… - Journal of hematology & …, 2020 - Springer
Pancreatic ductal adenocarcinoma (PDAC) is a malignancy characterized by a poor
prognosis and high mortality rate. Genetic mutations and altered molecular pathways serve …

[HTML][HTML] Spatial CRISPR genomics identifies regulators of the tumor microenvironment

M Dhainaut, SA Rose, G Akturk, A Wroblewska… - Cell, 2022 - cell.com
While CRISPR screens are helping uncover genes regulating many cell-intrinsic processes,
existing approaches are suboptimal for identifying extracellular gene functions, particularly …

Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer

G Petroni, LC Cantley, L Santambrogio… - Nature Reviews …, 2022 - nature.com
A variety of targeted anticancer agents have been successfully introduced into clinical
practice, largely reflecting their ability to inhibit specific molecular alterations that are …

[HTML][HTML] Cancer immunotherapy with γδ T cells: many paths ahead of us

D Kabelitz, R Serrano, L Kouakanou, C Peters… - Cellular & molecular …, 2020 - nature.com
Abstract γδ T cells play uniquely important roles in stress surveillance and immunity for
infections and carcinogenesis. Human γδ T cells recognize and kill transformed cells …

[HTML][HTML] Intricacies of TGF-β signaling in Treg and Th17 cell biology

J Wang, X Zhao, YY Wan - Cellular & molecular immunology, 2023 - nature.com
Balanced immunity is pivotal for health and homeostasis. CD4+ helper T (Th) cells are
central to the balance between immune tolerance and immune rejection. Th cells adopt …

[HTML][HTML] Anti-TGF-β/PD-L1 bispecific antibody promotes T cell infiltration and exhibits enhanced antitumor activity in triple-negative breast cancer

M Yi, Y Wu, M Niu, S Zhu, J Zhang, Y Yan… - … for Immunotherapy of …, 2022 - ncbi.nlm.nih.gov
Background Agents blocking programmed cell death protein 1/programmed death-ligand 1
(PD-1/PD-L1) have been approved for triple-negative breast cancer (TNBC). However, the …

Localization, tissue biology and T cell state—implications for cancer immunotherapy

JM Schenkel, KE Pauken - Nature Reviews Immunology, 2023 - nature.com
Tissue localization is a critical determinant of T cell immunity. CD8+ T cells are contact-
dependent killers, which requires them to physically be within the tissue of interest to kill …

TGF-β1–a truly transforming growth factor in fibrosis and immunity

M Lodyga, B Hinz - Seminars in cell & developmental biology, 2020 - Elsevier
Abstract 'Jack of all trades, master of everything'is a fair label for transforming growth factor
β1 (TGF-β)–a cytokine that controls our life at many levels. In the adult organism, TGF-β1 is …

[HTML][HTML] Mesenchymal stem cells and their microenvironment

J Liu, J Gao, Z Liang, C Gao, Q Niu, F Wu… - Stem Cell Research & …, 2022 - Springer
Mesenchymal stem cells (MSCs), coming from a wide range of sources, have multi-
directional differentiation ability. MSCs play vital roles in immunomodulation, hematopoiesis …

[HTML][HTML] Applications of patient-derived tumor xenograft models and tumor organoids

GJ Yoshida - Journal of hematology & oncology, 2020 - Springer
Patient-derived tumor xenografts (PDXs), in which tumor fragments surgically dissected from
cancer patients are directly transplanted into immunodeficient mice, have emerged as a …